Sfoglia per Autore
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT
2003-01-01 Adamo, Vincenzo; Scimone, A.; Spitaleri, G.; Alafaci, Elisabetta; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Maisano, C.; Zanghi', Mariangela
Breast. La terapia primaria: stato dell'arte
2004-01-01 Adamo, Vincenzo; Rossello, R.; Spitaleri, G.; Adamo, Barbara; Garipoli, Claudia
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study
2005-01-01 Adamo, Vincenzo; G., Ferrandina; M., Spada; F., Ferrau; G., Condemi; L., DI LULLO; D., Lorusso; R., Rossello; Garipoli, Claudia
A randomized factorial trial of sequential doxrubicina and CMF vs CMF and chemoterapy alone vs chemoterapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
2005-01-01 S., De Placido; M., De Laurentis; M. De Lena V., Adamo; Altavilla, Giuseppe; Garipoli, Claudia
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen
2005-01-01 Adamo, Vincenzo; Magno, Carlo; Spitaleri, G; Garipoli, Claudia; Maisano, Carmelo; Alafaci, Elisabetta; Adamo, B; Rossello, R; Scandurra, G; Scimone, Andrea
Ruolo della capecitabinanei tumori gastroentericiDalla monoterapia all'associazione nel trattamento della malattia metastatica del colon-retto:ruolo della capecitabina
2006-01-01 Garipoli, Claudia
Combination of Gemcitabine (GEM and Liposomal Pegylate Doxorubicin (PLD) in recurrent/ metastatic breast carcinoma: a phase II study.
2006-01-01 Adamo, Vincenzo; Gabriella, Ferrandina; Rosalba, Rossello; Garipoli, Claudia; Adamo, Barbara; MARIA CLAUDIA, Masi; Vito, Lorusso; Giovanni, Condemi; Francesco, Ferrau; Giovanni, Scambia
Impact of integrated treatments on patient management in solid tumors: From diagnosis to palliative care.
2006-01-01 Adamo, Vincenzo; Ferraro, G; Adamo, B; Franchina, T; Garipoli, Claudia; Pergolizzi, Stefano
Temozolamide plus oral vinorelbine in the treatment of brain metastases from solid tumours in heavily pre- treated patients.
2006-01-01 Adamo, Vincenzo; Scimone, A; Scandurra, G; Franchina, Tindara; Ferraro, Giuseppa; Caristi, Nicola; Garipoli, Claudia; Montalto, E.
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care.
2006-01-01 Adamo, Vincenzo; Ferraro, Giuseppa; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia
Safety and activity of trastuzumab (TRA) containing therapies as treatment of metastatic breast cancer(MBC): a five year experience.
2007-01-01 R., Rossello; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M. R., Valerio; A., Russo; Adamo, Vincenzo
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience
2007-01-01 Adamo, Barbara; Franchina, Tindara; R., Rossello; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M., Valerio; A., Russo; Adamo, Vincenzo
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients.
2007-01-01 Adamo, Vincenzo; Iorfida, Monica; Montalto, E; Festa, Vincenzo; Garipoli, Claudia; Scimone, Andrea; Zanghi', Mariangela; Caristi, Nicola
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER
2008-01-01 Adamo, Barbara; Iorfida, M; Condemi, G; Garipoli, Claudia; Ferraro, Giuseppa; Montalto, E; Pastura, G; Ferrandina, G; Adamo, Vincenzo
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience.
2009-01-01 Adamo, Barbara; Franchina, Tindara; Denaro, Nerina; Garipoli, Claudia; Ferraro, Giuseppa; Briguglio, Roberta; Ricciardi, GIUSEPPINA ROSARIA; P., Gambadauro; G., Ferrandina; Adamo, Vincenzo
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer.
2009-01-01 Ferraro, Giuseppa; Rossello, R.; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Garipoli, Claudia; Zanghi', Mariangela; Arcana’, C.; Briguglio, R.; Mesiti, Mario; Adamo, Vincenzo
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ?
2010-01-01 Franchina, Tindara; Scimone, Andrea; Ferraro, Giuseppa; Garipoli, Claudia; Zanghi', Mariangela; Berenato, Rosa; Briguglio, Roberta; Noto, Laura; Proto, Claudia; Adamo, Vincenzo
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications
2010-01-01 Adamo, Vincenzo; Ieni, Antonio; Colonese, Francesca; Adamo, Barbara; Ricciardi, Grr; Caristi, Nicola; Ferraro, Giuseppa; Garipoli, Claudia; Giuffre', Giuseppe; Tuccari, Giovanni
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications.
2010-01-01 Adamo, V; Ieni, Antonio; Colonese, F; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, N; Ferraro, G; Garipoli, Claudia; Giuffrè, G; Tuccari, G.
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC).
2011-01-01 Franchina, Tindara; Ferlazzo, Nadia; Colonese, Francesca; Alafaci, Elisabetta; Aquino, A. D'; Ferraro, Giuseppa; Garipoli, Claudia; Maisano, C.; Picciotto, Maria; Curro', Monica; Ientile, Riccardo; Adamo, Vincenzo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT | 1-gen-2003 | Adamo, Vincenzo; Scimone, A.; Spitaleri, G.; Alafaci, Elisabetta; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Maisano, C.; Zanghi', Mariangela | |
Breast. La terapia primaria: stato dell'arte | 1-gen-2004 | Adamo, Vincenzo; Rossello, R.; Spitaleri, G.; Adamo, Barbara; Garipoli, Claudia | |
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study | 1-gen-2005 | Adamo, Vincenzo; G., Ferrandina; M., Spada; F., Ferrau; G., Condemi; L., DI LULLO; D., Lorusso; R., Rossello; Garipoli, Claudia | |
A randomized factorial trial of sequential doxrubicina and CMF vs CMF and chemoterapy alone vs chemoterapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer | 1-gen-2005 | S., De Placido; M., De Laurentis; M. De Lena V., Adamo; Altavilla, Giuseppe; Garipoli, Claudia | |
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen | 1-gen-2005 | Adamo, Vincenzo; Magno, Carlo; Spitaleri, G; Garipoli, Claudia; Maisano, Carmelo; Alafaci, Elisabetta; Adamo, B; Rossello, R; Scandurra, G; Scimone, Andrea | |
Ruolo della capecitabinanei tumori gastroentericiDalla monoterapia all'associazione nel trattamento della malattia metastatica del colon-retto:ruolo della capecitabina | 1-gen-2006 | Garipoli, Claudia | |
Combination of Gemcitabine (GEM and Liposomal Pegylate Doxorubicin (PLD) in recurrent/ metastatic breast carcinoma: a phase II study. | 1-gen-2006 | Adamo, Vincenzo; Gabriella, Ferrandina; Rosalba, Rossello; Garipoli, Claudia; Adamo, Barbara; MARIA CLAUDIA, Masi; Vito, Lorusso; Giovanni, Condemi; Francesco, Ferrau; Giovanni, Scambia | |
Impact of integrated treatments on patient management in solid tumors: From diagnosis to palliative care. | 1-gen-2006 | Adamo, Vincenzo; Ferraro, G; Adamo, B; Franchina, T; Garipoli, Claudia; Pergolizzi, Stefano | |
Temozolamide plus oral vinorelbine in the treatment of brain metastases from solid tumours in heavily pre- treated patients. | 1-gen-2006 | Adamo, Vincenzo; Scimone, A; Scandurra, G; Franchina, Tindara; Ferraro, Giuseppa; Caristi, Nicola; Garipoli, Claudia; Montalto, E. | |
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. | 1-gen-2006 | Adamo, Vincenzo; Ferraro, Giuseppa; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia | |
Safety and activity of trastuzumab (TRA) containing therapies as treatment of metastatic breast cancer(MBC): a five year experience. | 1-gen-2007 | R., Rossello; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M. R., Valerio; A., Russo; Adamo, Vincenzo | |
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience | 1-gen-2007 | Adamo, Barbara; Franchina, Tindara; R., Rossello; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M., Valerio; A., Russo; Adamo, Vincenzo | |
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. | 1-gen-2007 | Adamo, Vincenzo; Iorfida, Monica; Montalto, E; Festa, Vincenzo; Garipoli, Claudia; Scimone, Andrea; Zanghi', Mariangela; Caristi, Nicola | |
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER | 1-gen-2008 | Adamo, Barbara; Iorfida, M; Condemi, G; Garipoli, Claudia; Ferraro, Giuseppa; Montalto, E; Pastura, G; Ferrandina, G; Adamo, Vincenzo | |
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. | 1-gen-2009 | Adamo, Barbara; Franchina, Tindara; Denaro, Nerina; Garipoli, Claudia; Ferraro, Giuseppa; Briguglio, Roberta; Ricciardi, GIUSEPPINA ROSARIA; P., Gambadauro; G., Ferrandina; Adamo, Vincenzo | |
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. | 1-gen-2009 | Ferraro, Giuseppa; Rossello, R.; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Garipoli, Claudia; Zanghi', Mariangela; Arcana’, C.; Briguglio, R.; Mesiti, Mario; Adamo, Vincenzo | |
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? | 1-gen-2010 | Franchina, Tindara; Scimone, Andrea; Ferraro, Giuseppa; Garipoli, Claudia; Zanghi', Mariangela; Berenato, Rosa; Briguglio, Roberta; Noto, Laura; Proto, Claudia; Adamo, Vincenzo | |
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications | 1-gen-2010 | Adamo, Vincenzo; Ieni, Antonio; Colonese, Francesca; Adamo, Barbara; Ricciardi, Grr; Caristi, Nicola; Ferraro, Giuseppa; Garipoli, Claudia; Giuffre', Giuseppe; Tuccari, Giovanni | |
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. | 1-gen-2010 | Adamo, V; Ieni, Antonio; Colonese, F; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, N; Ferraro, G; Garipoli, Claudia; Giuffrè, G; Tuccari, G. | |
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). | 1-gen-2011 | Franchina, Tindara; Ferlazzo, Nadia; Colonese, Francesca; Alafaci, Elisabetta; Aquino, A. D'; Ferraro, Giuseppa; Garipoli, Claudia; Maisano, C.; Picciotto, Maria; Curro', Monica; Ientile, Riccardo; Adamo, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile